Fibromyalgia Trial, Recruiting (NCT06250491)

Fibromyalgia Trial, Recruiting NCT06250491 Sponsor: Nadine ATTAL Condition: Fibromyalgia

Printed from Voxsanity (voxsanity.com.au) — NCT06250491 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Fibromyalgia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had ongoing pain for at least 6 months, it rates at least 4 out of 10 in severity, and it is present every day or almost every day
You have been diagnosed with either nerve-related pain (neuropathic pain) or fibromyalgia, confirmed using standard medical tools
Any medications you take for pain have stayed the same for at least one month
You are able to complete questionnaires and can understand and speak French

Who may not be able to join:

You have a medical reason that would make a brain stimulation treatment called rTMS (repetitive Transcranial Magnetic Stimulation) unsafe for you (confirm with trial site)
You have previously been treated with rTMS
You have a serious condition that is actively getting worse, such as cancer
You have been diagnosed with psychosis (a condition affecting how the mind processes reality)
You currently misuse or abuse alcohol, drugs, or other mind-altering substances

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nadine ATTAL, Assistance Publique - Hôpitaux de Paris

Phone: 0033149095931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06250491

Sponsor: Nadine ATTAL

Phase: Not Applicable

Status: Recruiting

Condition: Fibromyalgia

Trial contact: 0033149095931

More information: https://clinicaltrials.gov/study/NCT06250491

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had ongoing pain for at least 6 months, it rates at least 4 out of 10 in severity, and it is present every day or almost every day
You have been diagnosed with either nerve-related pain (neuropathic pain) or fibromyalgia, confirmed using standard medical tools
Any medications you take for pain have stayed the same for at least one month
You are able to complete questionnaires and can understand and speak French

Who may not be able to join:

You have a medical reason that would make a brain stimulation treatment called rTMS (repetitive Transcranial Magnetic Stimulation) unsafe for you (confirm with trial site)
You have previously been treated with rTMS
You have a serious condition that is actively getting worse, such as cancer
You have been diagnosed with psychosis (a condition affecting how the mind processes reality)
You currently misuse or abuse alcohol, drugs, or other mind-altering substances

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nadine ATTAL

Registry

ClinicalTrials.gov

Start date

30 January 2024

Est. completion

30 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Effects of rTMS versus sham rTMS on pain relief at 13 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov